Replies to post #40879 on Biotech Values

[gofishmarko]

Osiris (OSIR) is another company to keep an eye on in the GVHD area. They're in P3 with Prochymal ( adult stem cells ) for steroid-refractory GVHD and have Orphan status in the US and EU.

OSIR was one of the best performing IPOs last year.